• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Weekly Enforcement Report: Drug Testing Fraud Dominates

Weekly Enforcement Report: Drug Testing Fraud Dominates

by Rachel Muenz | May 17, 2023 | News, Open Content

Last week’s three key cases included two involving drug testing that was either medically unnecessary, or not provided at all.

Labs in Court: Lab Settles Kickback Allegations for $5.9M

Labs in Court: Lab Settles Kickback Allegations for $5.9M

by Glenn S. Demby | May 3, 2023 | Essential, Lab Compliance Advisor, Labs in Court-lca

Two companies settle kickback and FCA-related claims, a qui tam case is tossed, and a lab tech loses a workplace harassment case.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Urine Drug & Genetic Testing Remain Top Enforcement Targets

Urine Drug & Genetic Testing Remain Top Enforcement Targets

by Rachel Muenz | May 3, 2023 | Enforcement-lca, Essential, Lab Compliance Advisor

In an analysis of enforcement actions from the end of 2022 to early spring 2023, cases involving urine drug testing were the most prevalent.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Illegal Marketing Commissions Arrangements Cost Toxicology Lab $5.9 Million

Illegal Marketing Commissions Arrangements Cost Toxicology Lab $5.9 Million

by Glenn S. Demby | Apr 18, 2023 | News, Open Content

Recent case shows that toxicology labs and drug testing remain a primary target for federal enforcement agencies.

Labs in Court: Three Lawsuits Tossed

Labs in Court: Three Lawsuits Tossed

by Glenn S. Demby | Mar 24, 2023 | Essential, Lab Compliance Advisor, Labs in Court-lca

In this month’s roundup, three cases—including two whistleblower lawsuits and one workplace discrimination case—get dismissed.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com